Protocol Information

If you are interested in learning more about this study, please call or email the contact person below

Title Effect of Testosterone Replacement on Erythropoietin Stimulating agent use in End stage Renal Disease patients
Description Study visits will occur at Erie County Medical Center in Buffalo
Objective This research is being done because low testosterone is associated with anemia. Replacing testosterone increases the hemoglobin (blood) levels. In renal failure hemoglobin levels are low and they are improved by giving erythropoietin injections. The purpose of this study is to see if replacing testosterone results in reduction in the requirements of erythropoietin

Keywords: End Stage Renal Disease, renal failure, kidney disease, anemia, low testosterone
Principal Investigator DANDONA, PARESH; DANDONA, PARESH
Age Group Adult
Drugs Involved
Clinical Trials.gov
Status Open
Key Eligibility End Stage Renal Disease
Anemia
Low Testosterone
Disease Group Blood Diseases; Endocrine Diseases; Kidney Diseases/Transplant
Treatment testosterone
Contact MEGHAN KIRSCH
716-898-1950
meghanki@buffalo.edu